Samuel Olalekan Akinyemi is a Nigerian-born doctor who once worked as a labourer on construction sites before traveling abroad to further his studies.
His recent involvement in the discovery of a groundbreaking cancer vaccine in Russia marks a milestone in his career and in the global fight against cancer.
Dr. Samuel Olalekan Akinyemi (born in 1994) is a 30-year-old oncologist at the Ufa Clinic of the Bashkir State Medical University.
His journey is a testament to determination, resilience, and dedication to education.
From the streets of Lagos to global medical achievements, Dr. Akinyemi’s life story is one of remarkable transformation.
Early Life In Nigeria
Dr. Akinyemi was born in Lagos, Nigeria (unverified). He attended United Methodist/Anglican Grammar School for his secondary education and completed his National Youth Service Corps (NYSC) in Nigeria in 2012.
He completed his National Youth Service Corps (NYSC) in Nigeria in 2012.
He initially pursued his undergraduate studies in civil engineering inspired by his father’s profession.
However, he was always drawn to medicine. He completed his National Youth Service Corps (NYSC) in Nigeria in 2012 before moving to Russia in 2015 to study medicine at Bashkir State Medical University in Ufa.
His parents were very supportive, agreeing to fund his education.
He studied Russian for six months in Volgograd under the guidance of a Nigerian curator who was recruiting applicants.
There, he studied Russian language for six months. In interviews, Dr. Akinyemi has expressed gratitude for the support of his parents throughout his educational journey.
He enjoys working at the BSMU Clinic due to its modern equipment and supportive colleagues.
During his tenure at the university, Dr. Akinyemi demonstrated a keen interest in urology and oncology, which later became the focal points of his research and professional career.
His commitment to these specialties is evident through his numerous publications and contributions to the medical field.
In 2021, Samuel received Russian citizenship. Samuel Akinyemi: Academic And Professional Career He pursued his medical studies at Bashkir State Medical University, where he was enrolled from November 3, 2015, to June 30, 2022, specializing in general medicine.
At Bashkir State Medical University, he was also employed ats a Lecturer assistant from 2022-11-01 to 2027-11-01.
On December 13-14 2019, he participated in the 10th Volga Region Surgery Olympiad 2019 held at the Samara State Medical University where he got 2nd place in the competition “Craniotomy”.
Dr. Akinyemi’s academic career is marked by a focus on oncology and urology. He is currently an assistant at Bashkir State Medical University, where he is involved in both clinical practice and research.
He finished his residency on July 11, 2024, and is working as an oncology intern at the BSMU Clinic.
In addition to his medical duties, he teaches English at the university and high school.
In the summer, he works at language camps for children, where schoolchildren learn English with native speakers. During one of these camps, Akinyemi saved a drowning child.
After completing his medical education, he got employed by Bashkir State Medical University, his expertise span multiple discipline within medicine, with a practical focus on oncology and immunology.
Dr. Akinyemi’s work includes extensive research into cancer treatments and vaccines.
He has also published numerous research and article.
Dr. Akinyemi is multilingual; he speaks German (Deutsch), Russian, Yoruba, and English.
● Community Engagement
Beyond his academic responsibilities, Dr Akinyemi is actively involved in church activities. While in nigeria, he was in the choir and a member of Redeemed Christian Church of God (RCCG) in Nigeria.
watch video here;
Read more here: https://reportafrique.com/news/africa/nigeria/samuel-akinyemi-cancer-vaccine/
Stay ahead with the latest updates! Join The ConclaveNG on WhatsApp and Telegram for real-time news alerts, breaking stories, and exclusive content delivered straight to your phone. Don’t miss a headline — subscribe now!
